Clinical Trial Update: Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the clinical and economic outcomes of ceftaroline fosamil for acute bacterial skin and skin structure infections associated with MRSA o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• Teflaro (ceftaroline fosamil)

Snippet

Sponsor: Wayne State University | Conditions: Skin Diseases, Infectious, Staphylococcal Skin Infections | Phase 4 | Status: COMPLETED